Curran Simpson
2020
In 2020, Curran Simpson earned a total compensation of $1.8M as EVP, Chief Operations and Technology Officer at Regenxbio, a 4% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $174,000 |
|---|---|
| Option Awards | $1,132,325 |
| Salary | $428,152 |
| Other | $16,388 |
| Total | $1,750,865 |
Simpson received $1.1M in option awards, accounting for 65% of the total pay in 2020.
Simpson also received $174K in non-equity incentive plan, $428.2K in salary and $16.4K in other compensation.
Rankings
In 2020, Curran Simpson's compensation ranked 6,130th out of 13,090 executives tracked by ExecPay. In other words, Simpson earned more than 53.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,130 out of 13,090 | 53rd |
Division Manufacturing | 2,529 out of 5,620 | 55th |
Major group Chemicals And Allied Products | 1,014 out of 2,253 | 55th |
Industry group Drugs | 879 out of 1,953 | 55th |
Industry Biological Products, Except Diagnostic Substances | 213 out of 411 | 48th |
Source: SEC filing on April 7, 2022.
Simpson's colleagues
We found four more compensation records of executives who worked with Curran Simpson at Regenxbio in 2020.